Home »
The Type 1 Diabetes Grand Challenge is a partnership between the Steve Morgan Foundation, Diabetes UK and Breakthrough T1D.
We are united by our ambition to cure type 1 diabetes
For 100 years insulin has been the only treatment for type 1 diabetes but we’re on the cusp of a new era. The partnership is investing £50 million into the most promising projects led by exceptional scientists to fast-track discoveries that will lead to life-changing new treatments and ultimately a cure.
By harnessing the power of collaboration, targeting research areas with the greatest potential, and stimulating bold, innovative research at scale, we’re creating change that will improve the lives of millions of people with type 1 diabetes.
Founding partners
The Steve Morgan Foundation
The Steve Morgan Foundation is passionately committed to changing lives for good, by working with partners that make a positive difference to those in need. Founded in 2001 by businessman and philanthropist, Steve Morgan CBE, we provide funding, support, expertise and best practice to the charities and organisations we support. By harnessing the power of working together, we address a range of areas including poverty, homelessness, health and wellbeing, and education and training, and have helped to improve the quality of life for more than four million people. In April 2022, the Foundation announced this pioneering new £50m partnership with Diabetes UK and JDRF UK, the Type 1 Diabetes Grand Challenge.
Diabetes UK
Diabetes UK’s vision is to create a world where diabetes can do no harm. It is the largest charitable investor in diabetes research in the UK and has been funding excellence in diabetes research for over 85 years. The charity invests in research on type 1, type 2, gestational and rarer types of diabetes and currently funds 140 research projects worth around £32 million.
Breakthrough T1D
Breakthrough T1D (formerly JDRF) is the leading global organisation funding type 1 diabetes research. Its mission is to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications. To accomplish this, Breakthrough T1D has invested more than £1 billion since its inception, collaborating with the most talented minds to develop and deliver a pipeline of innovative therapies to people living with type 1 diabetes.Putting people affected by type 1 diabetes at the heart of research.
The Type 1 Diabetes Grand Challenge brings together scientists and the type 1 community to drive forward progress in areas that matter most to people with type 1.
